» Articles » PMID: 30894633

Structural Determinants of Inhibition of Porphyromonas Gingivalis Gingipain K by KYT-36, a Potent, Selective, and Bioavailable Peptidase Inhibitor

Overview
Journal Sci Rep
Specialty Science
Date 2019 Mar 22
PMID 30894633
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Porphyromonas gingivalis is a member of the dysbiotic oral microbiome and a "keystone pathogen" that causes severe periodontal disease, which is among the most prevalent infectious diseases. Part of the virulence factors secreted by P. gingivalis are the essential cysteine peptidases gingipain K (Kgp) and R (RgpA and RgpB), which account for 85% of the extracellular proteolytic activity of the pathogen and are thus prime targets for inhibition. We report the high-resolution (1.20 Å) complex structure of Kgp with KYT-36, a peptide-derived, potent, bioavailable and highly selective inhibitor, which is widely used for studies in vitro, in cells and in vivo. Sub-nanomolar inhibition of Kgp is achieved by tight binding to the active-site cleft, which is covered for its sub-sites S through S' under establishment of nine hydrophobic interactions, 14 hydrogen bonds and one salt bridge. In addition, an inhibitor carbonyl carbon that mimics the scissile carbonyl of substrates is pyramidalized and just 2.02 Å away from the catalytic nucleophile of Kgp, CSγ. Thus, the crystal structure emulates a reaction intermediate of the first nucleophilic attack during catalysis of cysteine peptidases. The present study sets the pace for the development of tailored next-generation drugs to tackle P. gingivalis.

Citing Articles

Computational Studies on Recent Congeners of Fluoroquinolones and Nitroimidazoles for Their Use in Periodontal Therapy.

Natarajan P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4731-S4740.

PMID: 40061649 PMC: 11888705. DOI: 10.4103/jpbs.jpbs_1235_24.


Gingipains protect Porphyromonas gingivalis from macrophage-mediated phagocytic clearance.

Widziolek M, Mieszkowska A, Marcinkowska M, Salamaga B, Folkert J, Rakus K PLoS Pathog. 2025; 21(1):e1012821.

PMID: 39836688 PMC: 11801703. DOI: 10.1371/journal.ppat.1012821.


Limited proteolysis of neutrophil granule proteins by the bacterial protease RgpB depletes neutrophil antimicrobial capacity.

Cooper K, Wielento A, Morris S, Terekhova M, Rodriguez-Hernandez C, Potempa B J Leukoc Biol. 2024; 117(2).

PMID: 39319408 PMC: 11878996. DOI: 10.1093/jleuko/qiae209.


The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight.

Wang A, Zhai Z, Ding Y, Wei J, Wei Z, Cao H Front Immunol. 2024; 15:1430001.

PMID: 39131163 PMC: 11310172. DOI: 10.3389/fimmu.2024.1430001.


Linking Periodontitis with Inflammatory Bowel Disease through the Oral-Gut Axis: The Potential Role of .

Huang X, Li Y, Zhang J, Feng Q Biomedicines. 2024; 12(3).

PMID: 38540299 PMC: 10968003. DOI: 10.3390/biomedicines12030685.


References
1.
de Diego I, Veillard F, Sztukowska M, Guevara T, Potempa B, Pomowski A . Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem. 2014; 289(46):32291-32302. PMC: 4231702. DOI: 10.1074/jbc.M114.602052. View

2.
Kadowaki T, Baba A, Abe N, Takii R, Hashimoto M, Tsukuba T . Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol Pharmacol. 2004; 66(6):1599-606. DOI: 10.1124/mol.104.004366. View

3.
Sztukowska M, Veillard F, Potempa B, Bogyo M, Enghild J, Thogersen I . Disruption of gingipain oligomerization into non-covalent cell-surface attached complexes. Biol Chem. 2012; 393(9):971-7. PMC: 3488288. DOI: 10.1515/hsz-2012-0175. View

4.
Schuttelkopf A, van Aalten D . PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 8):1355-63. DOI: 10.1107/S0907444904011679. View

5.
Koziel J, Potempa J . Protease-armed bacteria in the skin. Cell Tissue Res. 2012; 351(2):325-37. PMC: 3560952. DOI: 10.1007/s00441-012-1355-2. View